About REV-MED
REV-MED is a company based in Seongnam-si (South Korea) founded in 2018.. REV-MED offers products and services including TriCell, PRP, PRP UNI, Hilthera 4.0, and OnyRay. REV-MED operates in a competitive market with competitors including Isolere Bio, ExBiome, Zepteon, VIRAPUR and Norgen Biotek, among others.
- Headquarter Seongnam-si, South Korea
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of REV-MED
REV-MED offers a comprehensive portfolio of products and services, including TriCell, PRP, PRP UNI, Hilthera 4.0, and OnyRay. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Biologic for cell therapy in regenerative medicine applications.
Product for platelet-rich plasma preparation and concentration.
System for unified platelet-rich plasma processing.
Device for advanced cell separation in medical settings.
Equipment for bone marrow and cell concentration.
Tool for autologous cell processing applications.
System for handling patient-derived cells.
Device for dual-cell therapy development.
Product for stromal vascular fraction extraction.
Funding Insights of REV-MED
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by REV-MED
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - REV-MED
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rev-Med Comparisons
Competitors of REV-MED
REV-MED operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Isolere Bio, ExBiome, Zepteon, VIRAPUR and Norgen Biotek, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
A platform for biotherapeutics purification is provided using TFF technology.
|
|
| domain | founded_year | HQ Location |
Develops innovative diagnostic technologies for cancer detection from blood samples.
|
|
| domain | founded_year | HQ Location |
Biomolecular separation tools for antibody potency evaluation are developed.
|
|
| domain | founded_year | HQ Location |
Provides viral reagents and assay services for scientific and medical research.
|
|
| domain | founded_year | HQ Location |
Offers kits and services for RNA, DNA extraction, purification, and genomics research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about REV-MED
When was REV-MED founded?
REV-MED was founded in 2018.
Where is REV-MED located?
REV-MED is headquartered in Seongnam-si, South Korea. It is registered at Seongnam-si, Gyeonggi-do, South Korea.
What does REV-MED do?
REV-MED was founded in 2018 and is headquartered in Seongnam-si, South Korea. The company operates within the medical or healthcare sector, inferred from its name and domain rev-med.co.kr. Specific details on services, operations, or industry focus remain unavailable. Its location supports regional activities in South Koreas biotech or pharmaceutical landscape, though comprehensive data is limited for investor analysis.
Who are the top competitors of REV-MED?
REV-MED's top competitors include Isolere Bio, Zepteon and GenTegra.
What products or services does REV-MED offer?
REV-MED offers TriCell, PRP, PRP UNI, Hilthera 4.0, and 5 more products and services.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.